Hook & thesis
Perpetua Resources (PPTA) is no longer a speculative shell story; at $28.96 the market is pricing a development company with a near-term path to production and exposure to antimony - a commodity suddenly framed as strategic by Washington. Near-term permitting milestones and continued flows of Pentagon and federal support for critical minerals make PPTA a tactical long while the Stibnite Gold Project gains visible momentum.
My trade thesis is straightforward: enter at $29.00 with a mid-term target of $36.00 and a stop at $25.00. That setup captures upside toward the recent 52-week high ($37.37) while limiting downside if construction or permitting stalls. The trade is a play on re-rating as project milestones, financing execution and commodity narratives translate into valuation expansion.
What Perpetua does and why the market should care
Perpetua Resources is an exploration and development-stage miner focused on redeveloping the Stibnite Gold Project in Idaho. The project's mineralization is described across Hangar Flats, West End and Yellow Pine deposits and the company is positioning the asset to produce both gold and antimony (an increasingly strategic metal used in electronics, flame retardants and defense applications).
The market cares because two trends are converging. First, the U.S. government has prioritized domestic critical-minerals supply chains - the Pentagon allocated multibillion-dollar programs that favor onshore projects. Second, antimony demand and pricing have received renewed attention: industry commentary points to a global antimony market growing toward an estimated $4.3-4.4 billion by 2035. Together, these tailwinds lift development stories that can deliver domestic supply, and Perpetua sits squarely in that category.
Key data points that support the thesis
Use the table below for a snapshot of the facts I lean on:
| Metric | Value |
|---|---|
| Current price | $28.96 |
| Market cap | $3.53B |
| Enterprise value | $3.06B |
| Shares outstanding | 121,872,684 |
| Float | 113,049,098 |
| Cash on balance sheet | $40.93M |
| Free cash flow (trailing) | -$60.87M |
| EPS (trailing) | -0.36 |
| 52-week range | $8.84 - $37.37 |
| Average daily volume (2 weeks) | ~1.97M |
| Short interest (03/13/2026) | 10,617,051 (~9.4% of float) - 7.18 days to cover |
How to read the numbers
The market cap of ~$3.5B and enterprise value near $3.06B reflect a company that already carries a development-stage premium. That premium is reasonable if the market believes permits, financing and construction at Stibnite will progress on schedule and that antimony offtake or price realization is attainable. At the same time EPS is negative (-$0.36) and free cash flow is negative (-$60.9M), which is expected for a development-stage miner but means equity holders remain sensitive to funding execution and any capex overruns.
Technical context
Price action is mixed but not hostile. The 20-day simple moving average sits near $28.80, the 50-day at $30.30 and the 10-day at $26.21. RSI at ~50 indicates neutral momentum; MACD is marginally bearish, implying consolidation rather than a decisive downtrend. Average volumes show institutional attention (two-week average ~1.97M), and short interest near 9.4% of the float creates the potential for periodic squeezes if positive news arrives.
Valuation framing
Perpetua trades like a development-stage project with strategic optionality. There are two components to the valuation case:
- Project value: The enterprise value of ~$3.06B already reflects expectations for Stibnite’s future production profile and byproduct credits (antimony). If the project reaches construction and early production on expected timelines, the valuation is defensible against peers at similar stage-plus-permit status.
- Optionality premium: a material portion of the market cap is a premium for strategic importance - domestic critical-minerals supply in a geopolitical environment that favors onshore producers. That premium can expand if offtake contracts, Pentagon support, or financing commitments accelerate.
Because Perpetua is pre-production, traditional mining multiples are not fully applicable: negative EPS and negative free cash flow mean equity is priced on prospective NAV and milestone delivery. Compared to its own history, the stock has run (52-week high $37.37) and the current $28.96 sits below that peak - allowing room to regain the high if catalysts land.
Catalysts to watch (2-5)
- Permitting and regulatory milestones for Stibnite - any affirmative decision or schedule clarity materially reduces execution risk and could lift the stock.
- Public or private offtake agreements for antimony or gold concentrates - confirmed contracts would de-risk revenue assumptions.
- Federal funding or Pentagon commitments toward domestic critical-minerals projects - additional grants or low-cost financing would improve project economics and valuation.
- Construction starts or staged capex confirmations and progress updates - visible build activity will support multiple expansion.
- Quarterly updates showing improved cash runway or successful equity / debt closings to fund near-term construction.
Trade plan (actionable)
My recommended entry is $29.00. Set a stop at $25.00 to limit downside if permitting or financing problems appear. The primary target is $36.00 (we're targeting a re-test of the recent 52-week high once catalysts confirm progress).
Horizon: mid term (45 trading days). I expect one or two high-probability catalysts to surface in this window - permit updates, funding announcements or material offtake news. If the stock quickly clears and holds above $33 on volume, consider tightening the stop to protect gains.
Alternative holds: If you want a longer-duration exposure to the project's execution, convert to a position trade and extend horizon to long term (180 trading days). That longer path requires tolerance for volatility and monitoring of construction milestones and capital raises.
Risks (balanced and explicit)
- Permitting and environmental risk: Stibnite is in a region with sensitive environmental constraints. Permit delays, additional mitigation requirements, or legal challenges would push timelines and increase capex.
- Financing and dilution risk: The company has negative free cash flow and will require meaningful capital to build. Equity raises or expensive debt would dilute shareholders and compress returns.
- Commodity price risk: While antimony is strategic, prices can move. A significant drop in gold or antimony prices would erode projected project economics and investor sentiment.
- Execution and capex overruns: Development projects are notorious for cost creep. A material capex overrun could change the valuation quickly and justify a lower multiple.
- Insider and market psychology risk: Recent insider sales (executive and director transactions reported earlier) can be read as portfolio-management rather than loss of conviction, but they add noise and can spook momentum buyers in the event of weaker updates.
- Short-interest volatility: High short interest (~9.4% of float) can exacerbate price moves both up and down. Positive news can cause sharp squeezes, but negative news can produce accelerated falls.
Counterarguments
Critics will point to the negative free cash flow, the high development-stage valuation and the reality that timelines for mining projects routinely slip. Those are fair - if permits or financing do not arrive on schedule, the market will re-rate PPTA lower very quickly. The balance of probabilities depends on whether Perpetua can convert headline-level support for domestic critical minerals into concrete project funding and offtake.
Conclusion and what would change my mind
Stance: I am constructive and recommend a tactical long with the plan above: entry $29.00, stop $25.00, target $36.00 on a mid-term (45 trading days) horizon. The trade captures the re-rating potential from visible project momentum and strategic antimony exposure while limiting downside if execution falters.
I will change my view if any of the following occur: (1) a major permitting setback or adverse regulatory decision; (2) material inability to secure near-term financing without severe dilution; (3) sustained commodity price weakness that meaningfully degrades project economics; or (4) clear evidence that construction timelines will be delayed by multiple quarters. Conversely, my conviction would increase if Perpetua signs binding offtake contracts, secures low-cost project financing, or posts verifiable construction milestones on schedule.
Trade carefully: PPTA offers real upside tied to project execution and a strategic metals narrative, but it is a development-stage stock where the timeline and financing path determine returns.